We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients (X-MEN)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01312363
First Posted: March 10, 2011
Last Update Posted: May 4, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Seoul National University Bundang Hospital
Seoul St. Mary's Hospital
Korea University
Bobath Memorial Hospital
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Hanyang University
Kwandong University Myongji Hospital
Inha University Hospital
SungAe General Hospital
Ewha Womans University
Inje University
Hanyang University Seoul Hospital
Kyunghee University Medical Center
Hallym University Medical Center
Pusan National University Hospital
Konyang University Hospital
Wonkwang University Sanbon Medical Center
Yong-in Hyoja Geriatric Hospital
Jeju National University
Dong-A University Hospital
Information provided by (Responsible Party):
SangYun Kim, Seoul National University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)